Drug discovery

Informatics
#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Webinar: Discover faster, more informed scientific decision-making

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

#Biotechnology #Cancer research #Drug discovery #Tumours

This week in Drug Discovery (20-24 July 2026) 

News round-up for 20-24 July by Megan Thomas, Content Team at DDW.  This week’s news roundup highlights the latest advances in cancer research and treatment, from promising clinical trial updates to discoveries that could improve the body’s immune response to tumours. The top stories include progress in… Read More

#News

Human kidneys
#Biotechnology #Clinical stage biotechnology #Drug discovery #Funding #Rege Nephro #Regenerative Medicine

Rege Nephro secures US$10.6m for ADPKD and beyond

Rege Nephro, a Japanese clinical-stage biotechnology company focused on iPS cell-based kidney regenerative medicine and drug discovery, has closed a financing round totalling approximately US$10.6 million. Through the issuance of Japan-Keep It Simple Security (J-KISS) share acquisition rights, proceeds are expected to support commercialisation activities for RN-014, the company’s lead… Read More

#News

Neuroscience concept
#Drug discovery #Gene therapy #Neurology #Neuroscience #Webinar

Register now: The advances in neuroscience drug discovery

Hosted by Drug Discovery World and supported by BioIVT, this webinar examines the advances, challenges and opportunities that exist in neuroscience drug discovery and development. You will hear from a number of experts who will discuss how both technology and scientific approaches are helping enable the development of… Read More

#News

#Biology #Clinical trials #Drug discovery #New approach methodologies (NAMs)

A turning point for human-based drug discovery 

Daniel Delubac, Chief Executive Officer at iOrganBio, looks at how technologies that mimic human behaviour can improve drug discovery efforts past animal models.  The US is signalling a decisive shift toward human-based drug discovery. In March, the National Institutes of Health (NIH) announced a $150 million investment to support the development of novel approaches that mimic human biology to reduce… Read More

#Exclusive Content

Vaccine vial and syringe
#Drug discovery #eBook #Immunology / Virology & Vaccines

eBook: The latest developments in vaccines and virology 

The 2025 Global Vaccines Market Report from the World Health Organization (WHO) reports a total financial value of $66 billion in 2024, though this is predicted to grow to $227.89 billion by 2034 due to the rising prevalence of infectious diseases and increasing demand for immunisation programmes. Read More

#News

Vaccines & virology eBook
#Drug discovery #eBook #Immunology / Virology & Vaccines

The latest developments in vaccines and virology

This eBook, sponsored by Emulate, explores the factors having the greatest influence on today’s vaccine discovery, from viral outbreaks to national health policy, and reviews the progress in vaccine development since the Covid-19 pandemic.

#DDW eBooks #Intelligence

#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Watch on-demand: Real-time chemistry coordination for modern drug discovery

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

International Space Station (ISS)
#Drug discovery #ETH Zurich #Switzerland

Swiss institutes pioneer microgravity drug discovery research

As the world celebrates International Moon Day (20 July), Switzerland is championing the opportunities space exploration opens for life sciences.  Leading international players including Starlab Space and Axiom Space have selected Switzerland as their European hub for the next generation of commercial orbital laboratories, supporting R&D in space.  “Swiss research… Read More

#Business & Investment #News #Trending News

MRI of the brain
#Drug discovery #epilepsy #Gene therapy

EpilepsyGTx partners with ClearPoint for gene therapy delivery  

Biotechnology company EpilepsyGTx has partnered with ClearPoint Neuro on a project that will support the targeted delivery of the biotech’s gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).  The agreement will see EpilepsyGTx use the ClearPoint SmartFlow Cannula and the ClearPoint Neuro Navigation system to administer EPY201 in its upcoming first-in-human Phase I/IIa clinical trial for FRE.  ClearPoint’s MRI-guided stereotactic… Read More

#News

#Biomedical research #Biotechnology #Drug discovery #Heart disease #mRNA-based vaccines

This week in Drug Discovery (13 – 17 July) 

News round-up for 13 – 17 July by Bruno Quinney, Content Team at DDW.  This week, a new drug has shown potential to treat heart disease. Elsewhere, Cancer Research UK is leading a global cancer trial.  The top stories:  New drug could treat common heart disease, study… Read More

#News

Heart
#Clinical trial #Drug discovery #Heart disease #The University of Manchester

New drug could treat common heart disease, study shows 

A new drug that reduces heart muscle thickening could represent a new treatment option for heart disease patients, a study says.  The TEMPEST trial, led by researchers at the University of Manchester, tested the drug trientine in 154 adults with hypertrophic cardiomyopathy in a year-long, placebo-controlled study. Read More

#News

#Drug discovery #Gene therapy #Neurology #Neuroscience #Webinar

How technology and science are driving neuroscience

Hosted by Drug Discovery World and supported by BioIVT, this webinar examines the advances, challenges and opportunities that exist in neuroscience drug discovery and development. You will hear from a number of experts who will discuss how both technology and scientific approaches are helping enable the development of… Read More

#News

#Alzheimer's #Alzheimer's Drug Discovery Foundation #Biomarkers #Drug discovery #Parkinson's #Partnership #The Michael J Fox Foundation #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

US$5m partnership targets Alzheimer’s and Parkinson’s biomarkers

The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) have announced a new US$5 million partnership to accelerate the development of minimally invasive biomarkers for measuring pathologies associated with Parkinson’s and Alzheimer’s diseases. Isobel Coleman, Chief Executive Officer of the Alzheimer’s Drug Discovery… Read More

#News

Immunotherapy
#AI #Drug discovery #Immunotherapy #Multi-omics #T cell engagers

How tech and collaboration are accelerating the development of T-cell engagers

Alistair Henry, Executive Vice President Chief Scientific Officer at UCB, explains that various factors that are helping drive the development of T-cell engagers (TCEs).  Why is immunotherapy discovery constantly evolving?   As scientists, we are trained to measure, analyse and interpret. We quantify binding affinities, map pathways, and build increasingly sophisticated models of disease. Read More

#Exclusive Content

#Clinical trial #DDII #Drug discovery #Immunology / Virology & Vaccines #Lung disease #Monoclonal antibodies #Psilocybin #UK

DDW Highlights: 14 July 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a nanoparticle vaccine showed potential to protect from a ‘tripledemic’. Elsewhere, could… Read More

#Podcasts